Massachusetts Pharmacy Workers Ordered to Stop Work
Massachusetts regulators have ordered all pharmacists and pharmacy technicians who worked at the Framingham company at the center of national fungal meningitis outbreak to immediately stop working in the drug-compounding industry.
The letter dated Oct. 31 from the Massachusetts Board of Registration in Pharmacy says the investigation into the outbreak has determined that pharmacists and pharmacy technicians employed by the New England Compounding Center “may present an immediate or serious threat to the public health, safety, and welfare and should immediately cease.”
The letter was obtained by The Boston Globe.
The company closed last month and recalled all of its products. A steroid produced at the company has been linked to 419 fungal meningitis cases and joint infections and 30 deaths, according to the Centers for Disease Control and Prevention.
- Work Safety Group Releases List of ‘Dirty Dozen’ Employers
- California Sees Two More Property Insurers Withdraw From Market
- Jury Awards $80M to 3 Former Zurich NA Employees for Wrongful Termination
- Florida’s Home Insurance Industry May Be Worse Than Anyone Realizes
- Report: Vehicle Complexity, Labor ‘Reshaping’ Auto Insurance and Collision Repair
- Poll: Consumers OK with AI in P/C Insurance, but Not So Much for Claims and Underwriting
- Ship Owner in Bridge Collapse Seeks to Limit Its Liability
- CoreLogic Report Probes Evolving Severe Convective Storm Risk Landscape